CEL-SCI Corporation (Amex: CVM) entered into an exclusive licensing agreement with Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) under which CEL-SCI ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE